Telix opens radiopharmaceutical facility in Australia for cancer treatment

Telix Pharmaceuticals has opened a radiopharmaceutical facility in Melbourne, Australia, to expedite the delivery of new cancer treatments. The facility aims to address manufacturing capacity challenges and bring production and patient administration closer together. Telix aims to shorten the time from early-stage trials to wider patient access by integrating all services on-site. Credit: PeopleImages / Shutterstock.com. Telix Pharmaceuticals has officially opened a radiopharmaceutical research, manufacturing, and treatment facility in Melbourne, Australia, to expedite the delivery of new treatments for cancer. Known as Telix Manufacturing Solutions North Melbourne (TMSNM), the site is described as the country’s first purpose-built facility to combine…

Source: Pharmaceutical Technology